Tracked shipping to South Africa with premium packaging for just R199 

Ship to
South Africa
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

Take advantage of this pre-sale
portada Targeting the Triple Negative Breast Tumour Microenvironment to Overcome Resistance to Immunotherapy
Type
Physical Book
Publisher
Author
Language
English
Pages
220
Format
Paperback
ISBN13
9780443456480

Targeting the Triple Negative Breast Tumour Microenvironment to Overcome Resistance to Immunotherapy

Eksteen, Carla; Engelbrecht, Anna-Mart (Author) · Academic Press · Paperback

Targeting the Triple Negative Breast Tumour Microenvironment to Overcome Resistance to Immunotherapy - Eksteen, Carla; Engelbrecht, Anna-Mart

New Book Imported to South Africa
Delivery: 21 Oct - 05 Nov Shipping: 52 to 58 business days.
R 3,810
R 3,810

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Targeting the Triple Negative Breast Tumour Microenvironment to Overcome Resistance to Immunotherapy"

Targeting the Triple Negative Breast Tumour Microenvironment to Overcome Resistance to Immunotherapy explores the critical role of the tumor microenvironment (TME) in driving immunotherapy resistance in triple-negative breast cancer (TNBC). It addresses the urgent need to understand and target the TME to improve therapeutic outcomes in this aggressive cancer subtype. The content gives insight into the complex interactions within the TME, including immune cells, fibroblasts, and extracellular matrix components, that contribute to drug resistance. It integrates recent advancements in 3D organoid platforms, spatial omics, and combination therapy strategies, providing mechanistic insights and practical approaches to reprogramming the TME for enhanced treatment response. Academics and clinicians benefit from a comprehensive resource that bridges basic science and clinical application. This book equips researchers with cutting-edge knowledge and translational strategies, fostering innovation in cancer therapy and offering a roadmap for future drug development to overcome immunotherapy resistance in TNBC.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews